Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8217132 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
A complete response on PET scan immediately after initial chemotherapy is associated with superior FFP and OS in stage I to II DLBCL. The use of PET scans as posttreatment surveillance is not associated with a survival advantage. LDH is not a sensitive marker for relapse. Our results argue for limiting the use of posttreatment surveillance in patients with limited-stage DLBCL.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Susan M. MD, Erqi L. MD, Michael S. MD, PhD, Margaret M. BA, Guofan MD, PhD, Andrew MD, Ranjana H. MD, Richard T. MD,